AzTrials
AzTrials

Tracheal IntubationNCT02590237

KingVision Video Laryngoscopy vs Direct Laryngoscopy - Equivalence Trial

A study testing Ambu KingVision Video Laryngoscope aBlade and Miller Direct Laryngoscopy in people with Tracheal Intubation, run by Ann & Robert H Lurie Children's Hospital of Chicago at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine whether the Ambu KingVision videolaryngoscope performs as well as direct laryngoscopy for intubating small children and infants. Read more about this study

Who is it for?
Ages Up to 2 yearsHealthy volunteers can take part
Conditions the study is for
Tracheal Intubation
What is being tested?
Ambu KingVision Video Laryngoscope aBlade and Miller Direct Laryngoscopy
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
1 siteUnited States
Study dates
Oct 2015to Sep 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Up to 2 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Patients at Lurie Children's Hospital undergoing surgery/procedure where intubation is indicated
  • American Society of Anesthesiology Class I-III patients

Who cannot join

  • Children with an expected difficult airway
  • A bleeding or blood clotting disorder

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Ann & Robert H Lurie Children's Hospital of Chicago

    Chicago, Illinois, 60611

Other trials in United States

About this study

Official title: A Clinical Evaluation of the King Vision Video Laryngoscope aBlade System in Children

The purpose of this study is to determine whether the Ambu KingVision videolaryngoscope performs as well as direct laryngoscopy for intubating small children and infants.

Read the detailed description

The goal of this prospective randomized study is to compare the Ambu KingVision Video Laryngoscope and direct laryngoscopy using the Miller Blade Laryngoscope.

The primary outcome of the study will be time to successful intubation. Other outcomes of clinical relevance such as first attempt success rates of intubation, grade of laryngeal view, percentage of glottic opening, number of insertion attempts, hemodynamic responses, and complications will also be assessed.

Being tested
Ambu KingVision Video Laryngoscope aBlade, Miller Direct Laryngoscopy
Keywords
Laryngoscopy, Video Laryngoscopy

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Ambu KingVision Video Laryngoscope aBladeDevice

    At time of tracheal intubation, the subject will be intubated using the Ambu KingVision Video Laryngoscope with a size 1 aBlade. The first attempt to successful intubation will be assessed. The Cormack Lehane and Percentage of Glottic Opening scores will be recorded. Information on time to glottic view, time to removal of the blade, and time of first capnography upstroke (successful intubation) will be recorded. Other parameters measured will be information on subsequent attempts, ease of tracheal tube insertion, and hemodynamic responses for 5 minutes.

  • Miller Direct LaryngoscopyDevice

    At time of tracheal intubation, the subject will be intubated using a Miller blade laryngoscope. The first attempt to successful intubation will be assessed. The Cormack Lehane and Percentage of Glottic Opening scores will be recorded. Information on time to glottic view, time to removal of the blade, and time of first capnography upstroke (successful intubation) will be recorded. Other parameters measured will be information on subsequent attempts, ease of tracheal tube insertion, and hemodynamic responses for 5 minutes.

Study groups in NCT02590237
Study groupRoleWhat they receive
Direct LaryngoscopyActive comparatorThe trachea will be intubated via direct laryngoscopy using a traditional straight blade (Miller) laryngoscope.
Receives: Device: Miller Direct Laryngoscopy
KingVision Video LaryngoscopeExperimentalThe trachea will be intubated using the Ambu KingVision Video Laryngoscope size 1 pediatric blade.
Receives: Device: Ambu KingVision Video Laryngoscope aBlade

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Time to Intubation

    Three timepoints will be recorded, beginning with insertion of the device past the lips into the mouth. These will include time to optimal glottic view, time to removal of device from mouth, and time to first CO2 capnography upstroke. The primary outcome measure will be total time to intubation, as the sum of all three timepoints.

    Measured: Assessed intraoperatively at time of intubation

Secondary outcomes (7)
  1. First Attempt Success Rate of Tracheal Intubation

    An attempt at tracheal intubation will be defined as entry of the device into the patient's mouth without the need to remove the device once entered and securing the airway.

    Measured: Assessed intraoperatively at time of intubation

  2. Grades of Laryngeal View

    Cormack Lehane (1-4) and percentage of glottic opening (POGO) (%) will be recorded after insertion of the laryngoscope

    Measured: Assessed intraoperatively at time of intubation

  3. Intubation Adjustments & Ease of Use

    Airway manipulations utilized and ease of use (Likert 1-5) will be assessed by the user following the intubation.

    Measured: Assessed intraoperatively following intubation

  4. Hemodynamic Parameters - Heart Rate

    Heart rate (beats per minute) will be assessed prior to intubation and at 1 minute intervals, for 5 minutes, following intubation.

    Measured: Assessed intraoperatively at time of and following intubation

  5. Hemodynamic Parameters - Blood Pressure

    Blood pressure (mmHg) will be assessed prior to intubation and at 1 minute intervals, for 5 minutes, following intubation.

    Measured: Assessed intraoperatively at time of and following intubation

  6. Intraoperative Complications

    Airway/device related complications including, laryngospasm, bronchospasm, oxygen desaturation, will be assessed at intubation, during the surgery, and after extubation while under the anesthesiologists care.

    Measured: Assessed intraoperatively

  7. Postoperative Complications

    Airway/device related complications including sore throat, hoarseness, persistent coughing, stridor, and others will be assessed in the post anesthesia care unit.

    Measured: Assessed postoperatively while admitted to the phase 1 recovery unit, approximately 30-60 minutes after surgery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Oct 2015 (estimated)
  2. Study startOct 2015
  3. Primary completionSep 2016
  4. Study completionSep 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02590237
Sponsor's protocol ID
2015-304
Status last verified
Sep 2016
First submitted
27 Oct 2015
Last updated
3 Oct 2016
Results posted
No
Data monitoring committee
No

Publications

  • Levitan RM, Heitz JW, Sweeney M, Cooper RM. The complexities of tracheal intubation with direct laryngoscopy and alternative intubation devices. Ann Emerg Med. 2011 Mar;57(3):240-7. doi: 10.1016/j.annemergmed.2010.05.035. Epub 2010 Jul 31.

    PubMed 20674088
  • Theiler L, Hermann K, Schoettker P, Savoldelli G, Urwyler N, Kleine-Brueggeney M, Arheart KL, Greif R. SWIVIT--Swiss video-intubation trial evaluating video-laryngoscopes in a simulated difficult airway scenario: study protocol for a multicenter prospective randomized controlled trial in Switzerland. Trials. 2013 Apr 4;14:94. doi: 10.1186/1745-6215-14-94.

    PubMed 23556410
  • Murphy LD, Kovacs GJ, Reardon PM, Law JA. Comparison of the king vision video laryngoscope with the macintosh laryngoscope. J Emerg Med. 2014 Aug;47(2):239-46. doi: 10.1016/j.jemermed.2014.02.008. Epub 2014 Apr 16.

    PubMed 24742495
  • Akihisa Y, Maruyama K, Koyama Y, Yamada R, Ogura A, Andoh T. Comparison of intubation performance between the King Vision and Macintosh laryngoscopes in novice personnel: a randomized, crossover manikin study. J Anesth. 2014 Feb;28(1):51-7. doi: 10.1007/s00540-013-1666-9. Epub 2013 Jun 30.

    PubMed 23812581
  • Jagannathan N, Hajduk J, Sohn L, Huang A, Sawardekar A, Albers B, Bienia S, De Oliveira GS. Randomized equivalence trial of the King Vision aBlade videolaryngoscope with the Miller direct laryngoscope for routine tracheal intubation in children <2 yr of age. Br J Anaesth. 2017 Jun 1;118(6):932-937. doi: 10.1093/bja/aex073.

    PubMed 28549081

Questions about this trial

What is this clinical trial studying?

A study testing Ambu KingVision Video Laryngoscope aBlade and Miller Direct Laryngoscopy in people with Tracheal Intubation, run by Ann & Robert H Lurie Children's Hospital of Chicago at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Oct 2016. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Time to Intubation (time frame: Assessed intraoperatively at time of intubation). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02590237, which also lists 5 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Oct 2016.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in